Clinical Trial Update: BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for BOXR1030 T Cells shows a Phase 1/2 study in GPC3-positive solid tumors, including hepatocellular carcinoma and additional indications;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Merkel Cell Carcinoma
• Myxoid Round Cell Liposarcoma
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• BOXR1030 T Cells

Snippet

Sponsor: Sotio Biotech Inc. | Conditions: Hepatocellular Carcinoma, Squamous Cell Carcinoma of the Lung | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING